Discontinued — last reported Q4 '24
STERIS Healthcare [Member] — Segment operating income increased by 8.3% to $246.92M in Q4 2024 compared to the prior quarter. Year-over-year, this metric grew by 10.3%, from $223.90M to $246.92M. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests improved operational efficiency or favorable product mix, whereas a decrease may signal rising input costs or pricing pressure in the healthcare market.
This metric measures the profitability of the Healthcare segment after accounting for direct costs and allocated operati...
Comparable to segment operating profit or EBITA reported by diversified medical technology companies with hospital-facing business units.
ste_segment_healthcare_member_segment_operating_income| Q2 '21 | Q3 '21 | Q4 '21 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q2 '24 | Q3 '24 | Q4 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $138.37M | $168.34M | $175.78M | $156.50M | $165.34M | $175.40M | $198.18M | $204.05M | $223.90M | $216.89M | $228.01M | $246.92M |
| QoQ Change | — | +21.7% | +4.4% | -11.0% | +5.6% | +6.1% | +13.0% | +3.0% | +9.7% | -3.1% | +5.1% | +8.3% |
| YoY Change | — | — | — | +13.1% | -1.8% | -0.2% | +26.6% | +23.4% | +27.7% | +9.4% | +11.7% | +10.3% |